InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by WIRTH PETER, Director. Director active across 2 companies, notably Forma Therapeutics Holdings, Inc.. Cumulatively, 7 filings have been recorded. Total volume traded: €506k. The latest transaction was disclosed on 8 June 2022 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations7 total
04,500 shares0
Common Stock
SEC:0000899243-22-021664:0·
07,763 shares0
Ordinary Shares
SEC:0001567619-22-000400·
07,763 shares0
Ordinary Shares
SEC:0001567619-22-000400:0·
€253,1284,000 shares@ €63.2820.011% mcap100.0% of flow
Ordinary Shares
SEC:0001567619-21-021802·
Ideal exit: 4 Sept 2022 (T+270)
€253,1284,000 shares@ €63.2820.011% mcap50.0% of flow
Ordinary Shares
SEC:0001567619-21-021802:0·
Ideal exit: 4 Sept 2022 (T+270)
02,750 shares0
Common Stock
SEC:0000899243-21-025089·
02,750 shares0
Common Stock
SEC:0000899243-21-025089:0·
7 of 7 declarations
About WIRTH PETER
Peter Wirth is a Board Member at Forma Therapeutics Holdings, Inc. and Zai Lab Ltd. He brings valuable expertise in the biopharmaceutical sector. As a Board Member, he oversees the development and innovation strategies of these companies, contributing to their success in the market.
